|
|
|
This is the preliminary program for the 2008 Joint Statistical
Meetings in Denver, Colorado.
|
|
|
The views expressed here are those of the individual authors and not necessarily those of the ASA or its board, officers, or staff. Back to main JSM 2008 Program page |
= Applied Session,
= Theme Session,
= Presenter|
|
||
109
|
Mon, 8/4/08, 8:30 AM - 10:20 AM | CC-607 |
| Statistical Inference in Clinical Trials - Contributed - Papers | ||
|
Biopharmaceutical Section, Biometrics Section |
||
| Chair(s): Amy Ko, Merck & Co., Inc. | ||
| 8:35 AM |
Testing the Assumption in Several Two-Sided Amalgamation-Based Tests for Dose Response —  Arthur Roth, Pfizer, Inc.
|
|
| 8:50 AM |
Preference-Based Estimates of Treatment Efficacy Among Compliant Patients in a Randomized Clinical Trial with a Continuous Outcome — Afisi S. Ismaila, McMaster University; Stephen Walter, McMaster University
|
|
| 9:05 AM |
Testing Medians of Skewed Distribution: A Case Study — Hongwei Wang, Merck Research Laboratories; Arvind K. Shah, Merck Research Laboratories
|
|
| 9:20 AM |
Statistical Power Simulations on the Choice of Baselines in Clinical Trials — Din Chen, South Dakota State University; Pinggao Zhang, Global Biometrics
|
|
| 9:35 AM |
Identification of Promising Subgroups in the Retrospective Analysis of Clinical Trials — Ilya Lipkovich, Eli Lilly and Company; Alex Dmitrienko, Eli Lilly and Company; Eric Su, Eli Lilly and Company; Jonathan Denne, Eli Lilly and Company; Gregory Enas, Eli Lilly and Company
|
|
| 9:50 AM |
Identifying Endpoints and Analysis Methodologies in the Assessment of Treatment Effects on Nocturia Episodes in Patients with Overactive Bladders — Xiaojiang Zhan, Merck & Co., Inc.; Liang Chen, Merck & Co., Inc.; Weili He, Merck Research Laboratories
|
|
| 10:05 AM | Floor Discussion | |
|
JSM 2008
For information, contact jsm@amstat.org
or phone (888) 231-3473. If you have questions about the Continuing Education program,
please contact the Education Department. |